An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Completed · Phase 3

Conditions studied: Early-Stage Parkinson's Disease

In brief

The objective of this open-label extension is to assess the safety and tolerability of long-term treatment of the rotigotine patch in subjects with early-stage idiopathic Parkinson's disease.

Key facts

Study ID

NCT00594165

Run by

UCB Pharma

People needed

217

Starts

2002-06-01

Expected to finish

2008-11-01

Last updated by the study team

2014-10-02

Who can join

Age: 31 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have completed six months of maintenance treatment in the SP512 double-blind trial

You may not qualify if…

• Subjects who had an ongoing serious adverse event from SP512 double-blind trial that was assessed as related to study medication

Where it is running

• Study site — Peoria, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Fountain Valley, California, United States
• Study site — Fresno, California, United States
• Study site — Los Angeles, California, United States
• Study site — Englewood, Colorado, United States
• Study site — Danbury, Connecticut, United States
• Study site — New Haven, Connecticut, United States
• Study site — Miami, Florida, United States
• Study site — Pompano Beach, Florida, United States
• Study site — Sunrise, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Fort Wayne, Indiana, United States
• Study site — New Orleans, Louisiana, United States
• Study site — Boston, Massachusetts, United States
• Study site — Southfield, Michigan, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — St Louis, Missouri, United States
• Study site — Henderson, Nevada, United States
• Study site — New Brunswick, New Jersey, United States
• Study site — Albany, New York, United States
• Study site — Louisville, New York, United States
• Study site — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.